Portfolio
2021 Investment Choices
Prof. Ewens
Investment | Status |
Adventure (Cao, Huang, Rui, Suezaki and Wang)
Investment | Status |
Still private | |
Still private | |
Oracle Health | Still private |
JMMC (Brown, Cui, Janosi, Riker and Sun)
Investment | Status |
Cortex | Still private |
Still private | |
Still private |
The Sharks (Bao, Koe, Nangia, Natarajan, Shao and Srikanth)
Investment | Status |
Still private | |
Still private | |
Oracle Health | Still private |
Unnamed (Dibble, Drango, Guerra, Lushtak and McCoy)
Investment | Status |
Still private | |
Still private | |
Cortex | Still private |
Venture Adventure (Bathwal, Berrigan, Kyme, Zeitlin and Zhou)
Investment | Status |
Still private | |
Cortex | Still private |
Still private |
2020 Investment Choices
Prof. Ewens
Investment | Status |
NowRx | Still private |
Still private | |
Still private |
Group 1 (Moraru, Rangaswamy, Varadarajan, Wang)
Investment | Status |
Still private | |
Commerce.ai | Still private |
Still private |
Group 2 (Chen, Gupta, Ho, Lee, Liang, Lu, Mercado and Mo)
Investment | Status |
Commerce.ai | Still private |
Still private | |
Still private |
Group 3 (Como, Holder, Mirchandani, Nair, Ravishankar, Rosner)
Investment | Status |
NowRx | Still private |
Still private | |
Still private |
Group 4 (Andrews, Cai, Johnson, Lettenberger, Pinkus, Yu)
Investment | Status |
Still private | |
Still private | |
MisoRobotics | Still private |
Group 5 (Deacon, Han, Lee, Pan, Qian and Qin)
Investment | Status |
Still private | |
Still private | |
Commerce.ai | Still private |
Group 6 (Barlow, Gerber, Jones, Lui, Ni, Porter and Wexler)
Investment | Status |
Still private | |
Monogram | Still private |
Still private |
Group 7 (Han, Huh, Kim, Kim, Kim and Pugnet)
Investment | Status |
NowRX | Still private |
Still private | |
Still private |
2019 Investment Choices
Prof. Ewens
Investment | Status |
Still private | |
Still private | |
Innovega | Still private |
Group 1 (Rosker, Sreedhar, Wu)
Investment | |
Still private | |
HyperSciences | Still private |
Still private |
Group 2 (Bhaumik, Boubezari, Lingineni, Shin)
Investment | |
Still private | |
Carrie | Still private |
Still private |
Group 3 (Abou-Zamam, Brotz, Du, Wang)
Investment | |
Still private | |
HyperSciences | Still private |
Still private |
Group 4 (Aceves, Gilani, Wu)
Investment | |
Still private | |
Grin | Still private |
Still private |
Group 5 (Chatterjee, Huffman)
Investment | |
Still private | |
Intro Blue | Still private |
Still private |
2018 Investment Choices
Prof. Ewens
Investment | Status |
| Still private |
VisitDays | Still private |
Still private |
Group 1
Investment | Status |
iTap | Still private |
| Still private |
| Still private |
Group 2
Investment | Status |
Kaptivating | Still private |
| Still private |
Medlio | Still private |
Group 3
Investment | Status |
Visitdays | Still private |
| Still private |
| Still private |
Group 4
Investment | Status |
Medlio | Still private |
| Still private |
| Still private |
2017 Investment Choices
Prof. Ewens
Investment | Status |
Aromyx | Still private |
| Still private |
| Still private |
Group 1
Investment | Status |
| Still private |
Venzee | Still private |
Still private |
Group 3
Investment | Status |
Aromyx | Still private |
| Still private |
Still private |
Group 4
Investment | Status |
Tallyfy | Still private |
| Still private |
Still private |
2016 Investment Choices
Prof. Ewens
Investment | Status |
| Founder left, probably failed. |
| Still private |
MyCrowdQA | Acquired by QASource in 2017 |
Group 1 [Chintalacharuru, Eck, Karan, Leishman, Smalley]
Investment | Status |
Roomi | Still private, raised Series A in 2017 |
| Founder left, probably failed. |
Still private |
Group 2 [Bhagavathi, Desai, Du, Hsu]
Investment | Status |
Specless | Still private |
| Acquired by Insight in 2019 |
Still private, raised Series A in 2017 |
Group 3 [Anderson, Harmon, Kishore, LaBaron]
Investment | Status |
Still private, raised Series A in 2017 | |
Acquired by SageGroup in 2017 | |
MyCrowd QA | Acquired by QASource in 2017 |
Group 4 [Huang, Pathireddy, Pathireddy]
Investment | Status |
Roomi | Still private, raised Series A in 2017 |
| Acquired by SageGroup in 2017 |
Still private |
Group 5 [Blackwood, Du, Lee, Navonne, Turban]
Investment | Status |
| Still private |
| Acquired by QASource in 2017 |
VIMOC | Failed in 2019 |
Group 6 [Koval, Lango, Liu, Medonca, Reed]
Investment | Status |
MyCrowd QA | Acquired by QASource in 2017 |
| Still private |
Acquired by SageGroup in 2017 |
2015 Investment Choices
Prof. Ewens
Investment | Status |
| Still private, raised $10m Series A in 2017 |
Caribou Biosciences | Still private, $30 series C in 2016 |
Still private, raised venture round in 2016 |
Group 1 [Thosouth, Koch, Romine,Flicker]
Still private, $30 series C in 2016 | |
Still private, raised venture round in 2016 | |
Tip Network | Acquired by netSpend 9/2015 undisclosed |
Group 2 [Hartz,Bunting,Van Brugen,Richard ]
Investment | Status |
Still private, raising $1m at $5m post-$ cap in 3/2016 | |
Coolchip | Still private, raised venture round in 2016 |
Acquired by netSpend 9/2015 undisclosed |
Group 3 [Viswanadham,Domrongkitchaiporn,Nguyen,Emezie]
Investment | Status |
CoolChip | Still private, raised venture round in 2016 |
Still private, raising $1m at $5m post-$ cap in 3/2016 | |
Still private, $30 series C in 2016 |
Group 4 [Xu,Imtiaz,Ko,Yeh,Zhao]
Investment | Status |
Still private, $70M series B on 9/1/2015 | |
CoolChips | Still private, raised venture round in 2016 |
Acquired by netSpend 9/2015 undisclosed |
Group 5 [Shiv Kumar,Tan,Li,Cheng,Chattergoon]
Investment | Status |
Coolchip | Still private, raised venture round in 2016 |
Still private, raised $10m Series A in 2017 | |
Acquired by Spacer in 2017 (unknown amount) |